The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established conventional synthetic DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus study

Further Publications Immunology

Passive maternal immunity in children born to women with systemic autoimmune rheumatic disease - A case-control study

J Autoimmun

Mazzucato-Puchner A, Ramspeck H, Ritschl V, Stamm T, Kuczwara V, Szlatinay A, Mandl P, Blüml S, Haslacher H, Baranyi U, Falcone V, Aletaha D, Rosta K

doi: 10.1016/j.jaut.2025.103439

Rheumatoid Arthritis

Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors

Semin Arthritis Rheum

Raskin N, Hiligsmann M, Rebutoc AR, Bansback N, Boonen A, Buchbinder R, Falahee M, Fraenkel L, Marshall DA, Maxwell L, Nieuwlaat R, Proulx L, Saadat P, Shea B, Tugwell P, Wiercioch W, Beaton D, Richards P, Schünemann H, Guillemin F, Hazlewood GS

doi: 10.1016/j.semarthrit.2025.152769

Rheumatoid Arthritis

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drug

Arthritis Care Res (Hoboken)

Xie F, Beukelman T, McCormick NP, Curtis JR

doi: 10.1002/acr.80010

Psoriasis

Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective study

J Eur Acad Dermatol Venereol

Miao Y, Beauchet A, Piram M, McPherson T, Torres T, Yesli Y, Aubert H, Bodemer C, Bertoli C, Tardieu M, Hubiche T, Bonniaud B, Neri I, Chessa MA, Lasek A, Prignano F, Barbarot S, Bursztejn AC, Leducq S, Sergeant M, Puzenat E, Chiaverini C, Sigg N, Mallet S, Miquel J, Pourchot D, Patel KX, Burden-Teh E, Flohr C, Di Lernia V, Mahé E, GrPso of the Société Française de Dermatologie; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique

doi: 10.1111/jdv.70108

Atopic DermatitisFurther Publications Dermatology

Development of a Patient Decision Aid for Atopic Dermatitis Systemic Treatments in Adults

JAMA Dermatol

Okereke R, Baghoomian W, Dunlap RR, Chang AD, Jacobson ME, Foster E, Fang MM, Simpson EL

doi: 10.1001/jamadermatol.2025.5912

Autoimmune Disease

Outcomes of respiratory syncytial virus infection in patients with systemic autoimmune rheumatic disease

Semin Arthritis Rheum

Enns JP, Wang J, Jiang B, Srivatsan S, Kowalski EN, Wang X, Williams ZK, Qian G, Hanberg J, Johnson C, Negron M, Bade KJ, Saavedra A, Mueller KT, Vanni KMM, Kotton CN, Sparks JA, Wallace ZS, Patel NJ

doi: 10.1016/j.semarthrit.2025.152846

Systemic Sclerosis

Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in systemic sclerosis: a real-world national cohort study

Rheumatology (Oxford)

Keret S, Yaari S, Shouval A, Sawaed A, Nemesh N, Kaly L, Awisat A, Rosner I, Rozenbaum M, Boulman N, Hardak E, Slobodin G, Rimar D

doi: 10.1093/rheumatology/keaf664

Osteoarthritis

The role of sex and systemic inflammation in the development of cardiovascular disease in osteoarthritis: A population-based cohort study using the CLSA

Semin Arthritis Rheum

Perruccio AV, Kral C, Yip C, Eder L, Power JD, Canizares M, Wilfong JM, Heckman G, Badley E

doi: 10.1016/j.semarthrit.2025.152804

Autoimmune Disease

Benefits of nintedanib continuation in systemic autoimmune rheumatic disease-related progressive pulmonary fibrosis: KEIO-SARD-ILD-cohort

Semin Arthritis Rheum

Suzuki K, Akiyama M, Shimanuki K, Fukui H, Kaneko Y

doi: 10.1016/j.semarthrit.2025.152891

Related content

Passive maternal immunity in children born to women with systemic autoimmune rheumatic disease - A case-control study

Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drug

Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective study

Development of a Patient Decision Aid for Atopic Dermatitis Systemic Treatments in Adults

Outcomes of respiratory syncytial virus infection in patients with systemic autoimmune rheumatic disease

Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in systemic sclerosis: a real-world national cohort study

The role of sex and systemic inflammation in the development of cardiovascular disease in osteoarthritis: A population-based cohort study using the CLSA

Benefits of nintedanib continuation in systemic autoimmune rheumatic disease-related progressive pulmonary fibrosis: KEIO-SARD-ILD-cohort